Carnegie Investment Counsel’s iShares iBonds Dec 2021 Term Corporate ETF IBDM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-20,849
Closed -$519K 472
2020
Q4
$519K Sell
20,849
-1,300
-6% -$32.5K 0.02% 296
2020
Q3
$555K Hold
22,149
0.03% 273
2020
Q2
$557K Sell
22,149
-1,948
-8% -$48.7K 0.03% 267
2020
Q1
$594K Hold
24,097
0.04% 250
2019
Q4
$601K Sell
24,097
-784
-3% -$19.6K 0.03% 282
2019
Q3
$622K Hold
24,881
0.04% 264
2019
Q2
$620K Sell
24,881
-7,800
-24% -$193K 0.04% 275
2019
Q1
$808K Hold
32,681
0.06% 234
2018
Q4
$796K Buy
+32,681
New +$793K 0.07% 209

Other funds holding IBDM

Carnegie Investment Counsel's IBDM Position: Q1 2021 in Review

Carnegie Investment Counsel sold out of iShares iBonds Dec 2021 Term Corporate ETF (IBDM) in Q1 2021, closing a stake of 20,849 shares — an estimated $519K sold.

Carnegie Investment Counsel first reported a position in IBDM in Q4 2018 and held it in 9 quarters. The position peaked at $808K in Q1 2019. 199 funds tracked by Wall St. Rank hold IBDM as of Q1 2021.

  • Carnegie Investment Counsel reported no remaining iShares iBonds Dec 2021 Term Corporate ETF position as of Q1 2021 after selling out during the quarter.
  • Carnegie Investment Counsel sold 20,849 iShares iBonds Dec 2021 Term Corporate ETF shares in Q1 2021, an estimated $519K.
  • Carnegie Investment Counsel first reported a position in iShares iBonds Dec 2021 Term Corporate ETF in Q4 2018 and held it in 9 quarters.
  • Carnegie Investment Counsel's iShares iBonds Dec 2021 Term Corporate ETF position peaked at $808K in Q1 2019.
  • 199 funds tracked by Wall St. Rank held iShares iBonds Dec 2021 Term Corporate ETF as of Q1 2021.

Based on Carnegie Investment Counsel's 13F filing for Q1 2021, filed 12 Apr 2021.